A frequent clinic question from endurance athletes concerns iron status and whether routine testing or supplementation is indicated. For most generally healthy adults without a history of iron overload disorders, a focused assessment of iron stores can be informative, but the decision to intervene requires more than a single laboratory value. The direct relationship between iron deficiency anemia and impaired endurance performance is well documented, yet the role of low iron stores in the absence of anemia remains a subject of careful clinical scrutiny.

Patient question

The typical inquiry arrives as: “My training volume has increased, and I feel more fatigued than usual. Should I get my iron checked, and would a supplement help even if I’m not anemic?” This question often comes from runners, triathletes, and cyclists who have heard that iron is critical for oxygen delivery and energy metabolism. The concern is reasonable, but the answer depends on individual laboratory values, dietary intake, training load, and—importantly—the absence of contraindications such as hereditary hemochromatosis or a history of hemolytic anemia.

Mechanism

Iron serves as a cofactor in hemoglobin synthesis and in mitochondrial enzymes responsible for oxidative phosphorylation. In states of iron deficiency, even before hemoglobin concentrations decline, tissue iron depletion may impair mitochondrial function and reduce energetic efficiency. This mechanistic rationale supports the plausibility that non-anemic iron deficiency could compromise endurance performance. However, the body tightly regulates iron absorption, and excess iron generates oxidative stress; thus, supplementation is not a benign intervention.

Evidence summary

Serum ferritin is the most useful single marker of iron stores in otherwise healthy athletes, though its interpretation requires consideration of the acute-phase response. A critical review of serum ferritin testing in endurance athletes—published in 1997—cautioned that while low ferritin may signal depleted stores, the direct link to performance impairment without anemia was not firmly established at that time. More recent data have refined the picture. A systematic review and meta-analysis by Burden and colleagues (2015) examined iron treatment in iron-deficient but non-anemic endurance athletes and found evidence for improved performance, particularly in measures of energetic efficiency and submaximal exercise capacity. Supporting this, a 2000 study by Hinton and colleagues demonstrated that iron supplementation improved endurance after training in iron-depleted, non-anemic women, with benefits seen in work rate and metabolic efficiency. Subsequent work by the same group showed that iron supplementation maintained ventilatory threshold and further improved energetic efficiency in iron-deficient non-anemic athletes. These findings are not universal across all populations; the strongest signal emerges in women with documented low ferritin (commonly below 20–30 ng/mL) and without confounding health conditions. For male athletes, the data are sparser, and the risk of undiagnosed hereditary hemochromatosis—a contraindication to iron supplementation—warrants particular caution.

Conservative recommendation

For most endurance athletes, a reasonable approach begins with dietary assessment and, when indicated, serum ferritin measurement. In the absence of anemia, supplementation is generally reserved for those with ferritin levels below 20 ng/mL, especially when accompanied by symptoms of fatigue or declining performance that cannot be explained by training load or other factors. Dosing should be conservative—typically 30–60 mg of elemental iron daily—with repeat ferritin testing after 8–12 weeks to avoid iron overload. Intravenous iron carries a risk of infusion reactions and anaphylaxis and should be limited to cases of confirmed iron deficiency anemia unresponsive to oral therapy or when oral iron is not tolerated. Iron can also decrease the absorption of medications such as methyldopa, fluoroquinolones, penicillin, and tetracyclines by forming insoluble complexes, so timing of doses matters. The practice does not apply to adolescents without documented deficiency, pregnant or lactating individuals without appropriate monitoring, or patients on glucose-lowering medications where gastrointestinal side effects may complicate management. Routine iron supplementation in the absence of documented deficiency is not supported by evidence and may cause harm.

Disclaimer

This column reflects a conservative clinical perspective and does not replace individualized evaluation. Athletes considering iron testing or supplementation should do so under the guidance of a healthcare professional who can interpret laboratory values in the context of their full health history. For personal medical concerns, please consult a qualified physician.